Dilawar Khan
Associate Professor
- Atta-Ur-Rahman School of Applied Biosciences
- 5190856139
Summary
Academic Background
PhD
(Cancer Biology/Cancer Stem Cells & Signaling/Biotech/Molecular Bio) Johann Wolfgang Goethe Universität Frankfurt am Main
April 01, 2012 - May 23, 2016
Honours and Awards
Scholarship
Merit Scholarship throughout under graduate studies
PhD Scholarship Germaany
PhD Scholarship for Germany under HEC 90% Overseas PhD scholarship, Phase II BATCH 3
Rs: 5.5 million
October 01, 2011
2nd Runner Up prize
2nd Runner Up prize, FICS 2018, NUST
Publications
Targeting Musashi-2 to counteract senescence and resistance in chronic myeloid leukemia: enhancing the efficacy of imatinib therapy
January 08, 2026
BMC Cancer - Volume:26, Article Number:41, Pages:12
Investigating the pathogenic potential of PKC-eta UTR variants in cancer progression
December 01, 2025
Computers in Biology and Medicine - Volume:199, Article Number 111283
TAM family kinases are potential candidate targets for therapeutic intervention in chronic myeloid leukemia
October 21, 2025
Discover Oncology - Volume:16, Issue:1, Article Number 1944
Anticancer role of Gramicidin A in myeloid leukemia
October 09, 2025
Discover Oncology - Volume:16, Issue:1, Article Number 1839
Zapotin mitigates breast cancer progression by targeting PKCε mediated glycolytic pathway regulation
April 28, 2025
BMC Cancer - Volume:25, Issue:1, Article Number 798
Unravelling the role of PRKCI and key-cancer related genes in breast cancer development and metastasis
March 18, 2025
Discover Oncology - Volume 16, Article Number 350
Imidazolium, pyridinium and pyrazinium based ionic liquids with octyl side chains as potential antibacterial agents against multidrug resistant uropathogenic E. coli
November 30, 2024
Heliyon - Volume 10, Issue 22, Article Number e39829
Effects of imidazole derivatives on cellular proliferation and apoptosis in myeloid leukemia
September 28, 2024
BMC Cancer - Volume 24, Article Number 1200
A nanoformulation of cisplatin with arabinoxylan having enhanced activity against hepatocellular carcinoma through upregulation of apoptotic and necroptotic pathways
May 30, 2024
Heliyon - Volume 10, Issue 10, Article Number e31057
Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia
October 01, 2022
Annals of Hematology - Volume 101, Issue 10, Pages 2179-2193
Biomarkers in Tumor Recurrence and Metastasis
May 28, 2022
Book on Cancer Biomarkers in Diagnosis and Therapeutics - 1st Edition, Chapter 8, Pages 201-227
Prevalence and assessment of associated risk factors of hepatitis B and C infections in low-socioeconomic communities
May 01, 2022
Future Virology - Volume 17, Issue 5, Pages 291-303
Silencing of Curlin Protein via M13 Phagemid‐Mediated Synthetic sRNA Expression Reduces Virulence in the Avian Pathogenic E. coli (APEC)
February 14, 2022
Current Microbiology - Volume 79, Article Number: 105
AXL Receptor Tyrosine Kinase: A Possible Therapeutic Target in Acute Promyelocytic Leukemia
June 17, 2021
BMC Cancer - Volume 21, Article Number 713
A short review on key role of plants and their extracts in boosting up immune response to combat COVID-19
May 26, 2021
Infectious Disorders Drug Targets - Pages 1-8
Insights into Acute Myeloid Leukemia: Critical Analysis on its Wide Aspects
December 31, 2020
Abasyn Journal of Life Sciences - Volume 3 Issue 2, Pages 1-9
In Silico Identification of Novel Acute Myeloid Leukemia Associated Missense SNPs in Human CEBPA Gene
December 31, 2020
Abasyn Journal of Life Sciences - Volume 3, Issue 2, Pages 10-24
5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
September 15, 2014
Cancer Research - Volume 74, Issue 18, Pages 5244-5255
Conferences
Induction of Fetal Hemoglobin by Targeted Deletion of Zinc Finger Domain Within BCL11A Gene using CRISPR-CAS9 Technology
June 08, 2023 - June 11, 2023
Irfan Hussain, Kainaat Mumtaz, Fizza Iftikhar, Safana Farooq, Syed Muhammad Areeb Ahmed, Dilawar Khan, Hammad Hass, Oliver Ottmann, Afsar Ali Mian,
European Hematology association congress 2023
ANTIBIOTICS; A POSSIBLE ALTERNATE TREATMENT OPTION FOR MYELOID LEUKEMIA
June 08, 2023 - June 11, 2023
Syeda Maham, Saba Naseem Awan, Fazal Adnan, Salik Javed Kakar, Afsar Ali Mian, Dilawar Khan,
European Hematology association congress 2023
Post Doc fellow
Agha Khan University
May 18, 2017 - September 17, 2017